Instead, the chromosomal translocations are thought to activate the expression of the MYB (or MYBL1) gene by recruiting distant enhancers that interact with the MYB promoter [11], implicating enhancer hijacking as a primary mechanism activating the MYB gene in ACC tumors. The gene discussed is MYB; the disease is adrenal cortex carcinoma.